Proxima, a dedicated MedTech contract research organization, announced a change in company ownership in a statement released by Billy Howell, Chairman of the Board. In conjunction with the purchase, Eric Ross has been appointed as the new Chief Executive Officer of Proxima. Billy Howell, Chairman of the Board, expressed his enthusiasm for the purchase, stating, “Proxima’s dedication to innovative MedTech creation over the years aligns perfectly with our vision for the Houston community.” Howell’s ownership also extends to HGI Clinical, a CRO dedicated to early-phase oncology and cell and gene therapy drug development. This synergy between Proxima and HGI Clinical is expected to create a robust platform for accelerated medical advancements.
Read the full article: Proxima Clinical Research Acquired //
Source: https://www.prnewswire.com/news-releases/proxima-clinical-research-acquired-names-industry-veteran-eric-ross-as-new-ceo-to-drive-growth-in-houston-medtech-hub-302606386.html